Piperazine derivatives and their use as synthesis intermediates

Piperazine derivatives and their use as synthesis intermediates

The present invention relates to new enantiomerically pure piperazine derivatives of formula (I) wherein Y represents hydroxy or a leaving group and n is 1, 2, 3, 4 or 5, and to their use as synthesis intermediates, especially for the preparation of pharmaceutically active compounds

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ATES CELAL, CAVOY EMILE, BOUVY DIDIER
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ATES CELAL
CAVOY EMILE
BOUVY DIDIER
description The present invention relates to new enantiomerically pure piperazine derivatives of formula (I) wherein Y represents hydroxy or a leaving group and n is 1, 2, 3, 4 or 5, and to their use as synthesis intermediates, especially for the preparation of pharmaceutically active compounds
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US7381821B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US7381821B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US7381821B23</originalsourceid><addsrcrecordid>eNrjZLAPyCxILUqsysxLVUhJLcosSyzJLEstVkjMS1EoyUjNLFIoLU5VSCxWKK7MA_KLM4sVMvNKUotyU1MyE0tSi3kYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSXxosLmxhaGFkaGTkTERSgB_pTFZ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Piperazine derivatives and their use as synthesis intermediates</title><source>esp@cenet</source><creator>ATES CELAL ; CAVOY EMILE ; BOUVY DIDIER</creator><creatorcontrib>ATES CELAL ; CAVOY EMILE ; BOUVY DIDIER</creatorcontrib><description>The present invention relates to new enantiomerically pure piperazine derivatives of formula (I) wherein Y represents hydroxy or a leaving group and n is 1, 2, 3, 4 or 5, and to their use as synthesis intermediates, especially for the preparation of pharmaceutically active compounds</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20080603&amp;DB=EPODOC&amp;CC=US&amp;NR=7381821B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20080603&amp;DB=EPODOC&amp;CC=US&amp;NR=7381821B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ATES CELAL</creatorcontrib><creatorcontrib>CAVOY EMILE</creatorcontrib><creatorcontrib>BOUVY DIDIER</creatorcontrib><title>Piperazine derivatives and their use as synthesis intermediates</title><description>The present invention relates to new enantiomerically pure piperazine derivatives of formula (I) wherein Y represents hydroxy or a leaving group and n is 1, 2, 3, 4 or 5, and to their use as synthesis intermediates, especially for the preparation of pharmaceutically active compounds</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAPyCxILUqsysxLVUhJLcosSyzJLEstVkjMS1EoyUjNLFIoLU5VSCxWKK7MA_KLM4sVMvNKUotyU1MyE0tSi3kYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSXxosLmxhaGFkaGTkTERSgB_pTFZ</recordid><startdate>20080603</startdate><enddate>20080603</enddate><creator>ATES CELAL</creator><creator>CAVOY EMILE</creator><creator>BOUVY DIDIER</creator><scope>EVB</scope></search><sort><creationdate>20080603</creationdate><title>Piperazine derivatives and their use as synthesis intermediates</title><author>ATES CELAL ; CAVOY EMILE ; BOUVY DIDIER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US7381821B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2008</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>ATES CELAL</creatorcontrib><creatorcontrib>CAVOY EMILE</creatorcontrib><creatorcontrib>BOUVY DIDIER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ATES CELAL</au><au>CAVOY EMILE</au><au>BOUVY DIDIER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Piperazine derivatives and their use as synthesis intermediates</title><date>2008-06-03</date><risdate>2008</risdate><abstract>The present invention relates to new enantiomerically pure piperazine derivatives of formula (I) wherein Y represents hydroxy or a leaving group and n is 1, 2, 3, 4 or 5, and to their use as synthesis intermediates, especially for the preparation of pharmaceutically active compounds</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US7381821B2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title Piperazine derivatives and their use as synthesis intermediates
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T23%3A44%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ATES%20CELAL&rft.date=2008-06-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS7381821B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true